HOME >> MEDICINE >> NEWS
Study Finds Less Intensive Treatments May Not Maintain HIV Suppression

Triple-drug treatment regimens appear to be superior to less intensive "maintenance" therapies at maintaining HIV suppression, a study supported by the National Institute of Allergy and Infectious Diseases (NIAID) suggests. Among individuals participating in the study, known as AIDS Clinical Trials Group (ACTG) 343, those who switched from three-drug to two- or one-drug treatment regimens were more likely to experience a resurgence in their HIV levels. A report of the study appears in the Oct. 29, 1998 issue of the New England Journal of Medicine. Similar findings from a French research study are reported in the same issue.

"These findings suggest that patients who have responded well to intensive antiretroviral therapy, as evidenced by prolonged suppression of HIV viral load, should continue with their current treatment regimen," says NIAID Director Anthony S. Fauci, M.D. "Recent research describing persistent HIV reservoirs in individuals receiving highly active antiretroviral therapy (HAART) - even after their viral loads have been driven below the level of detection by current assays - points to the same conclusion." He adds, however, that these data do not eliminate the possibility that this may be a successful strategy for some patients.

Begun in early 1997, ACTG 343 is the first large-scale clinical trial to investigate whether one- or two-drug therapies can hold virus production at bay after HIV levels are driven down by intensive therapy. The multicenter study enrolled more than 500 individuals, each of whom had HIV viral loads greater than 1,000 copies of RNA per milliliter (ml) of blood and at least 200 CD4+ T cells per cubic millimeter (mm3) of blood. During the induction, or initial, phase of the study, all individuals received the protease inhibitor indinavir (IDV) in combination with zidovudine (AZT) and lamivudine (3TC).

After six months, more than 300 individuals whose viral loads had been reduced to 200 or fewer copies of HIV
'"/>

Contact: John Bowersox
jbowersox@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
28-Oct-1998


Page: 1 2 3

Related medicine news :

1. Study of energy and health in Africa focuses spotlight on charcoal and forest management
2. Study shows promise in identifying kidney failure
3. Study shows patch therapy may be as effective as oral medications
4. Study shows soy is well accepted in school lunches
5. Study finds that coordinating care of chronically ill patients does not increase liability
6. Study provides new estimates of the causes of child mortality worldwide
7. Study finds factors linked to substance use disorder relapse among health care professionals
8. Study finds majority of women willing to accept cervical cancer vaccine for self and children
9. Study shows use of budesonide reduced the risk of asthma related events by 40% in children
10. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased
11. Study shows acrylamide in baked and fried food does not increase risk of breast cancer in women

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... PurhealthRX ... CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will ... and providing a CBD form that can be easily incorporated into liquid products, while ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that covers ... companies have a waiver for care if the client has a cognitive impairment diagnosis. ... pays for care, is often waived, so the benefits from their insurance start immediately,” ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... one of the most popular and least understood books in the Holy Scriptures, Revelation. ... descriptions that have baffled scholars for centuries. Many have tossed it off as mere ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
(Date:9/28/2017)... , Sept. 28, 2017 Cohen Veterans Bioscience ... the use of wearable and home sensors for real-time ... Early Signal Foundation, a nonprofit organization focused on disruptive ... provide an affordable analytical system to record and integrate ... ...
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
Breaking Medicine Technology:
Cached News: